3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
43
Carcinoma, Non-Small-Cell Lung
35
Breast Neoplasms
35
Triple Negative Breast Neoplasms
16
Neoplasms
15
Neoplasm Metastasis
14
Carcinoma
9
Adenocarcinoma
9
Lung Neoplasms
7
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Pancreatic Diseases
5
Cholangiocarcinoma
5
Carcinoma, Squamous Cell
5
Neoplasms by Site
4
Melanoma
4
Digestive System Neoplasms
4
Digestive System Diseases
4
Sarcoma
3
Pancreatic Adenocarcinoma
3
Neoplasms by Histologic Type
3
Inflammatory Breast Neoplasms
3
Endocrine System Diseases
3
Endocrine Gland Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Carcinoma, Ovarian Epithelial
3
Uveal Melanoma
2
Urinary Bladder Neoplasms
2
Interventions
Paclitaxel
19
pembrolizumab
16
Carboplatin
12
Bevacizumab
8
lenvatinib
6
rucaparib
5
Nivolumab
5
Megestrol Acetate
5
Radiation
4
Indocyanine Green
4
Gemcitabine
4
Cisplatin
4
tisotumab vedotin
3
temsirolimus
3
Sirolimus
3
Sentinel Lymph Node Biopsy
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
olaparib
2
niraparib
2
ixabepilone
2
iso-sulfan blue
2
irosustat
2
epacadostat
2
durvalumab
2
copanlisib
2
Trastuzumab
2
Taxes
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
130-nm albumin-bound paclitaxel
×
Clear all
No trials found.